柠檬苦素
顺铂
药理学
肝损伤
肝细胞
体内
脂质过氧化
化学
雷公藤醇
细胞凋亡
体外
医学
生物化学
氧化应激
生物
化疗
内科学
生物技术
作者
Yadie Xiang,Xumin Zhou,Zhen Hong,Dier Li,Menghua Zhong,Xue Hou,Song Duan,Yinyi Long,Xi Zeng,Yudan Chen,Jun Zhou,Dongning Liang,Haiyan Fu
标识
DOI:10.1016/j.biopha.2023.115680
摘要
Acute liver injury (ALI) is a common side effect of cisplatin treatment in the clinic and can lead to liver failure if not treated promptly. Previous studies have revealed that Limonin, a critical bioactive substance in citrus fruits, can protect multiple organs from various medical conditions. However, whether Limonin could ameliorate cisplatin-induced ALI remains unclear. In vivo and in vitro models were induced by cisplatin in the present study. Non-targeted metabolomics was employed to analyze the metabolic changes in the liver after ALI. In addition, molecular docking was utilized to predict the potential targets of Limonin. Limonin attenuated hepatic histopathological injury by reducing hepatocyte apoptosis, lipid peroxidation, and inflammation in cisplatin-challenged mice. Employing metabolomics, we revealed that Limonin mediated the balance of various disturbed metabolic pathways in the liver after cisplatin-induced ALI. Integrating public data mining, molecular docking studies, and in vitro experiments demonstrated that Limonin suppressed the expression and activity of its direct target, 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), in the liver, thus reducing the production of corticosterone (CORT), a key metabolite promoted hepatocyte apoptosis. Limonin improves the liver metabolic microenvironment by inhibiting 11β-HSD1 to protect against cisplatin-induced ALI.
科研通智能强力驱动
Strongly Powered by AbleSci AI